Topical vancomycin surgical prophylaxis in pediatric open craniotomies: an institutional experience

Restricted access

OBJECTIVE

Topical antimicrobial compounds are safe and can reduce cost and complications associated with surgical site infections (SSIs). Topical vancomycin has been an effective tool for reducing SSIs following routine neurosurgical procedures in the spine and following adult craniotomies. However, widespread adoption within the pediatric neurosurgical community has not yet occurred, and there are no studies to report on the safety and efficacy of this intervention. The authors present the first institution-wide study of topical vancomycin following open craniotomy in the pediatric population.

METHODS

In this retrospective study the authors reviewed all open craniotomies performed over a period from 05/2014 to 12/2016 for topical vancomycin use, SSIs, and clinical variables associated with SSI. Topical vancomycin was utilized as an infection prophylaxis and was applied as a liquid solution following replacement of a bone flap or after dural closure when no bone flap was reapplied.

RESULTS

Overall, 466 consecutive open craniotomies were completed between 05/2014 and 12/2016, of which 43% utilized topical vancomycin. There was a 1.5% SSI rate in the nontopical cohort versus 0% in the topical vancomycin cohort (p = 0.045). The number needed to treat was 66. There were no significant differences in risk factors for SSI between cohorts. There were no complications associated with topical vancomycin use.

CONCLUSIONS

Routine topical vancomycin administration during closure of open craniotomies can be a safe and effective tool for reducing SSIs in the pediatric neurosurgical population.

ABBREVIATIONS SSI = surgical site infection.

Article Information

Correspondence Gerald A. Grant: Stanford University/Lucile Packard Children’s Hospital, Stanford, CA. ggrant2@stanford.edu.

INCLUDE WHEN CITING Published online August 24, 2018; DOI: 10.3171/2018.5.PEDS17719.

A.L.H. and J.G.D.C. contributed equally to this work. S.H.C. and G.A.G. contributed equally to and share senior authorship of this work.

Disclosures The authors report no conflict of interest concerning the materials or methods used in this study or the findings specified in this paper.

© AANS, except where prohibited by US copyright law.

Headings

Figures

  • View in gallery

    All craniotomies included in the study classified by surgical diagnosis. Figure is available in color online only.

References

1

Abdullah KGAttiah MAOlsen ASRichardson ALucas TH: Reducing surgical site infections following craniotomy: examination of the use of topical vancomycin. J Neurosurg 123:160016042015

2

Armaghani SJMenge TJLovejoy SAMencio GAMartus JE: Safety of topical vancomycin for pediatric spinal deformity: nontoxic serum levels with supratherapeutic drain levels. Spine (Phila Pa 1976) 39:168316872014

3

Blomstedt GCKyttä J: Results of a randomized trial of vancomycin prophylaxis in craniotomy. J Neurosurg 69:2162201988

4

Bruny JLHall BLBarnhart DCBillmire DFDias MSDillon PW: American College of Surgeons National Surgical Quality Improvement Program Pediatric: a beta phase report. J Pediatr Surg 48:74802013

5

Caroom CTullar JMBenton EG JrJones JRChaput CD: Intrawound vancomycin powder reduces surgical site infections in posterior cervical fusion. Spine (Phila Pa 1976) 38:118311872013

6

Chotai SGuidry BSChan EWSborov KDGannon SShannon C: Unplanned readmission within 90 days after pediatric neurosurgery. J Neurosurg Pediatr 20:5425482017

7

Chotai SWright PWHale ATJones WAMcGirt MJPatt JC: Does intrawound vancomycin application during spine surgery create vancomycin-resistant organism? Neurosurgery 80:7467532017

8

Fang CZhu TZhang PXia LSun C: Risk factors of neurosurgical site infection after craniotomy: A systematic review and meta-analysis. Am J Infect Control 45:e123e1342017

9

Gans IDormans JPSpiegel DAFlynn JMSankar WNCampbell RM: Adjunctive vancomycin powder in pediatric spine surgery is safe. Spine (Phila Pa 1976) 38:170317072013

10

Ghobrial GMThakkar VAndrews ELang MChitale AOppenlander ME: Intraoperative vancomycin use in spinal surgery: single institution experience and microbial trends. Spine (Phila Pa 1976) 39:5505552014

11

Glotzbecker MPRiedel MDVitale MGMatsumoto HRoye DPErickson M: What’s the evidence? Systematic literature review of risk factors and preventive strategies for surgical site infection following pediatric spine surgery. J Pediatr Orthop 33:4794872013

12

Gnanalingham KKLafuente JThompson DHarkness WHayward R: Surgical procedures for posterior fossa tumors in children: does craniotomy lead to fewer complications than craniectomy? J Neurosurg 97:8218262002

13

Godil SSParker SLO’Neill KRDevin CJMcGirt MJ: Comparative effectiveness and cost-benefit analysis of local application of vancomycin powder in posterior spinal fusion for spine trauma: clinical article. J Neurosurg Spine 19:3313352013

14

Hedequist DHaugen AHresko TEmans J: Failure of attempted implant retention in spinal deformity delayed surgical site infections. Spine (Phila Pa 1976) 34:60642009

15

Khan NRThompson CJDeCuypere MAngotti JMKalobwe EMuhlbauer MS: A meta-analysis of spinal surgical site infection and vancomycin powder. J Neurosurg Spine 21:9749832014

16

Kim HSLee SGKim WKPark CWSon S: Prophylactic intrawound application of vancomycin powder in instrumented spinal fusion surgery. Korean J Spine 10:1211252013

17

Lassen BHelseth EEgge ADue-Tønnessen BJRønning PMeling TR: Surgical mortality and selected complications in 273 consecutive craniotomies for intracranial tumors in pediatric patients. Neurosurgery 70:9369432012

18

Lee IAgarwal RKLee BYFishman NOUmscheid CA: Systematic review and cost analysis comparing use of chlorhexidine with use of iodine for preoperative skin antisepsis to prevent surgical site infection. Infect Control Hosp Epidemiol 31:121912292010

19

National Healthcare Safety Network: Surgical Site Infection (SSI) Event. Atlanta: Centers for Disease Control and Prevention2018 (https://www.cdc.gov/nhsn/pdfs/pscmanual/9pscssicurrent.pdf) [Accessed July 13 2018]

20

O’Keeffe ABLawrence TBojanic S: Oxford craniotomy infections database: a cost analysis of craniotomy infection. Br J Neurosurg 26:2652692012

21

Pritchard LBaker CLeggett JSehdev PBrown ABayley KB: Increasing vancomycin serum trough concentrations and incidence of nephrotoxicity. Am J Med 123:114311492010

22

Ravikumar VHo ALPendhakar AVSussman ESKwong-Hon Chow KLi G: The use of vancomycin powder for surgical prophylaxis following craniotomy. Neurosurgery 80:7547582017

23

Sparling KWRyckman FCSchoettker PJByczkowski TLHelpling AMandel K: Financial impact of failing to prevent surgical site infections. Qual Manag Health Care 16:2192252007

24

Sweet FARoh MSliva C: Intrawound application of vancomycin for prophylaxis in instrumented thoracolumbar fusions: efficacy, drug levels, and patient outcomes. Spine (Phila Pa 1976) 36:208420882011

TrendMD

Metrics

Metrics

All Time Past Year Past 30 Days
Abstract Views 98 98 38
Full Text Views 68 68 28
PDF Downloads 72 72 33
EPUB Downloads 0 0 0

PubMed

Google Scholar